< Back to previous page

Publication

Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor alpha (FR alpha)-positive cancer

Journal Contribution - Journal Article Conference Contribution

Journal: ANNALS OF ONCOLOGY

ISSN: 0923-7534

Issue: 7

Volume: 33

Pages: S817 - S817

Publication year:2022

Institutional Repository URL: https://lirias.kuleuven.be/4054703
DOI: https://doi.org/10.1016/j.annonc.2022.07.720
WoS Id: 000866211600584

Accessibility:Closed